FinCanna Capital Corp (CSE:CALI) a royalty company for the U.S. licensed medical cannabis industry is pleased to announce that it will be presenting at the invitation-only New Green Frontier, cannabis investor conference to be held at The Arcadian Court in Toronto ON, Monday, November 19.

The conference, expected to be attended by over 350 investors, aims to connect cannabis companies across North America and accredited, institutional, and high-net worth cannabis investors to share insights and foster relationships that will help shape and advance the rapidly-growing industry.


FinCanna President and CEO Andriyko Herchak will deliver a main stage company presentation scheduled for 16:30EST. Mr. Herchak stated, “I am excited to have the opportunity to share our story and prospects for the future. We are committed to increasing our visibility in the investment community and the New Frontier Conference is an ideal venue for showcasing the potential of our company with a highly selective investor audience.”

Investors attending the event can look forward to presentations from management teams of leading cannabis companies, one-on-one meetings, hearing keynote speeches, and panel discussions touching upon topics such as Women in Cannabis, Navigating Capital Markets post-legalization, Growing Technologies, Cannabis-Infused Products and more. The New Green Frontier conference is presented by by SmallCapPower and Capital Ideas Media, the financial media division of Gravitas Financial Inc. The conference is invitation-only, but is available to be viewed via webcast at the link below: https://webinar.newgreenfrontier.com/attend-the-live-webinar/

About New Green Frontier

New Green Frontier is an invite-only cannabis investor conference focused on connecting high net worth investors and cannabis experts to the top cannabis companies from across North America. The conference is presented by SmallCapPower and Capital Ideas Media, the financial media division of Gravitas Financial Inc. along with Gravitas Securities in association with Thinking North, The Canadian Securities Exchange, North Lights Partners and Marigold PR. Event partners include Canada Cannabis Events and Bantr Inc. For more information, visit https://newgreenfrontier.com/ or email Sonia Bhalla, Client Relations Manager at SmallCapPower, (sonia@smallccappower.com).

About FinCanna Capital Corp.

FinCanna provides financing to top-tier companies in the licensed medical cannabis industry in exchange for a royalty on revenues. FinCanna, led by a team of finance and industry experts, is building its diversified portfolio of royalty investments in scalable, best-in-class projects and companies in U.S. legal states, with a focus on California. For additional information visit www.fincannacapital.com and FinCanna’s profile at www.sedar.com.

FinCanna Capital Corp.
Andriyko Herchak, CEO & Director

Investor Relations:

Arlen Hansen
Kin Communications
1-866-684-6730
CALI@kincommunications.com

Cautionary Note Regarding Forward-Looking Statements
Information set forth in this news release may involve forward-looking statements under applicable securities laws. Forward-looking statements are statements that relate to future, not past, events. In this context, forward-looking statements often address expected future business and financial performance, and often contain words such as “anticipate”, “believe”, “plan”, “estimate”, “expect”, and “intend”, statements that an action or event “may”, “might”, “could”, “should”, or “will” be taken or occur, or other similar expressions. All statements, other than statements of historical fact, included herein including, without limitation, statements about how the developing U.S. legal regime will impact the cannabis industry.  By their nature, forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements, or other future events, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others, the risks identified in the CSE listing statement and other reports and filings with the applicable Canadian securities regulators. Forward-looking statements are made based on management’s beliefs, estimates and opinions on the date that statements are made, and the respective companies undertakes no obligation to update forward-looking statements if these beliefs, estimates and opinions or other circumstances should change, except as required by applicable securities laws. Investors are cautioned against attributing undue certainty to forward-looking statements. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by applicable law.

Click here to connect with FinCanna Capital Corp (CSE:CALI) for an Investor Presentation. 

Source: globenewswire.ca

American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less